Use of acetyl L-carnitine in the therapeutic treatment of coma

Details Use of acetyl L-carnitine in the therapeutic treatment of coma Use of acetyl L-carnitine in the therapeutic treatment of coma

1992-01-03

1993-03-09

Waddell, Frederick E.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Radical -xh acid, or anhydride, acid halide or salt thereof...

A61K 31205

Patent

active

051928051

ABSTRACT:
The use is described of acetyl L-carnitine and some of its pharmacologically acceptable salts in the therapeutic treatment of coma. 2000-4000 mg/day of acetyl L-carnitine or an equivalent quantity of one of its pharmacologically acceptable salts is administered, preferably by the parenteral route.

REFERENCES:
patent: 4464393 (1984-08-01), Cavazza
patent: 4751242 (1988-06-01), Calvani et al.

Affiliated with

Also associated with

Rating

Use of acetyl L-carnitine in the therapeutic treatment of coma does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of acetyl L-carnitine in the therapeutic treatment of coma, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of acetyl L-carnitine in the therapeutic treatment of coma will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-211990